Vanguard Group Inc Regeneron Pharmaceuticals, Inc. Transaction History

Vanguard Group Inc

$4.96 Trillion
Q1 2024

A detailed history of Vanguard Group Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 8,930,241 shares of REGN stock, worth $8.75 Billion. This represents 0.17% of its overall portfolio holdings.

Number of Shares

8,930,241

Previous 8,838,285 1.04%

Holding current value

$8.75 Billion

Previous $7.76 Billion 10.73%

% of portfolio

0.17%

Previous 0.17%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$902.69 - $993.35 $83 Million - $91.3 Million	91,956 Added 1.04%	8,930,241 $8.6 Billion
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $30.8 Million - $35.1 Million	39,780 Added 0.45%	8,838,285 $7.76 Billion
Q3 2023 Nov 14, 2023	SELL	$692.45 - $844.37 $40.5 Million - $49.4 Million	-58,533 Reduced 0.66%	8,798,505 $7.24 Billion
Q2 2023 Aug 14, 2023	BUY	$700.03 - $830.35 $3.44 Million - $4.08 Million	4,917 Added 0.06%	8,857,038 $6.36 Billion
Q1 2023 Jul 14, 2023	BUY	$680.49 - $826.97 $9,526 - $11,577	14 Added 0.0%	8,852,121 $7.27 Billion

Q1 2023 May 15, 2023	BUY	$680.49 - $826.97 $88.2 Million - $107 Million	129,659 Added 1.49%	8,852,107 $7.27 Billion
Q4 2022 Feb 10, 2023	BUY	$705.89 - $766.39 $52.5 Million - $57 Million	74,323 Added 0.86%	8,722,448 $6.29 Billion
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $44.4 Million - $56 Million	77,380 Added 0.9%	8,648,125 $5.96 Billion
Q2 2022 Aug 12, 2022	BUY	$548.35 - $738.84 $115 Million - $155 Million	210,415 Added 2.52%	8,570,745 $5.07 Billion
Q1 2022 May 13, 2022	BUY	$595.12 - $698.43 $120 Million - $141 Million	201,815 Added 2.47%	8,360,330 $5.84 Billion
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $47.4 Million - $58.5 Million	87,234 Added 1.08%	8,158,515 $5.15 Billion
Q3 2021 Nov 12, 2021	BUY	$574.03 - $680.96 $58.3 Million - $69.2 Million	101,621 Added 1.28%	8,071,281 $4.88 Billion
Q2 2021 Aug 13, 2021	BUY	$472.8 - $558.54 $3.77 Billion - $4.45 Billion	7,969,660 New	7,969,660 $4.45 Billion

Others Institutions Holding REGN

# of Institutions

1,426

Shares Held

82.1M

Call Options Held

835K

Put Options Held

1.46M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $105B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Regeneron Pharmaceuticals, Inc. Transaction History